Genipin blues: An alternative non-toxic crosslinker for heart valves?

Journal of Heart Valve Disease

Volumn 17, Issue 6, 2008, Pages 682-688

  Somers, Pamela ^a   De Somer, Filip ^a   Cornelissen, Maria ^b   Bouchez, Stefaan ^a   Gasthuys, Frank ^b   Narine, Kishan ^a   Cox, Eric ^b   Van Nooten, Guido ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS LINKING REAGENT; GENIPIN; GLUTARALDEHYDE; IMMUNOGLOBULIN G; IRIDOID; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BIOPROSTHESIS; BLOOD; CHEMISTRY; HEART VALVE PROSTHESIS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; PULMONARY VALVE; SHEEP; SWINE; TENSILE STRENGTH; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BIOPROSTHESIS; CROSS-LINKING REAGENTS; GLUTARAL; HEART VALVE PROSTHESIS; IMMUNOGLOBULIN G; INFLAMMATION; IRIDOIDS; MICROSCOPY, ELECTRON, TRANSMISSION; PULMONARY VALVE; SHEEP; SWINE; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 59649130112     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sodian R, Hoerstrup SP, Sperling JS, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 2000;102:22-29
2. Cebotari S, Mertsching H, Kallenbach K, et al. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002;106:63-68
3. Hilbert SL, Yanagida R, Souza J, et al. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep. J Heart Valve Dis 2004;13:831-840
4. Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits. Circulation 2000;102:50-55
5. Rieder E, Kasimir MT, Silberhumer G, et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004;127:399-405 (Pubitemid 38176643)
6. Cipriano PR, Billingam ME, Oyer PE, Kutsche LM, Stinson EB. Calcification of porcine heart valves: A radiographic and light microscopy study. Circulation 1982;66:100-104
7. Speer DP, Chvapil M, Eskelson CD, Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mater Res 1980;14:753-764 (Pubitemid 11234031)
8. Chang Y, Hsu CK, Wei HJ, et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: In vitro and in vivo studies. J Biotechnol 2005;120:207-219 (Pubitemid 41429281)
9. Chang Y, Tsai CC, Liang HC, Sung HW. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 2002;23:2447-2457 (Pubitemid 34288486)
10. Narine K, Claeys E, Cornelissen M, et al. Readily available porcine aortic valve matrices for use in tissue valve engineering. Is cryopreservation an option? Cryobiology 2006;53:169-181 (Pubitemid 44353449)
11. Narine K, Kramm K, Dumont K, et al. Hydrodynamic evaluation of kangaroo aortic valve matrices for tissue valve engineering. Artif Organs 2006;30:432-439 (Pubitemid 43824188)
12. Narine K, Dewever O, Van Valckenborgh D, et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng 2006;12:2707-2716 (Pubitemid 46141239)
13. De Rooster H, Cox E, Van Bree H. Prevalence and relevance of antibodies to type-I and-II collagen in synovial fluid of dogs with cranial cruciate ligament damage. Am J Vet Res 2000;61:1456-1461
14. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-666 (Pubitemid 24148315)
15. Caterina MJ, Devreotes PN. Molecular insights into eukaryotic chemotaxis. FASEB J 1991;5:3078-3085 (Pubitemid 21892868)
16. Van Nooten G, Somers P, Cornelissen M, et al. Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV® valves in the sheep model. Interact Cardiovasc Thorac Surg 2006;5:544-549 (Pubitemid 44504065)
17. Simon P, Kasimir MT, Rieder E, Weigel G. Tissue engineering of heart valves: Immunologic and inflammatory challenges of the allograft scaffold. Prog Pediatr Cardiol 2006;21:161-165
18. Nimni ME, Cheung D, Strates B, Kodama M, Sheikh K. Bioprosthesis derived from cross-linked and chemically modified collagenous tissues. In: Nimni ME (ed.), Collagen. CRC Press, Boca Raton, FL, Vol. III, 1988:1-38
19. Sung HW, Hsu CS, Wang SP, Hsu HL. Degradation potential of biological tissues fixed with various fixatives: An in vitro study. J Biomed Mater Res 1997;34:147-155
20. Woodroof EA. Use of glutaraldehyde and formaldehyde to process tissue heart valves. J Bioeng 1978;2(1-2):1-9 (Pubitemid 8346265)
21. Human P, Zilla P. Inflammatory and immune processes: The neglected villain of bioprosthetic degeneration? J Long Term Eff Med Implants 2001;11:199-220 (Pubitemid 34211355)
22. Huang LL, Sung HW, Tsai CC, Huang DM. Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent. J Biomed Mater Res 1998;42:568-576 (Pubitemid 28503762)
23. Koo HJ, Song YS, Kim HJ, et al. Anti-inflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 2004;495:201-208 (Pubitemid 38891877)
24. Kitano A, Saika S, Yamanaka O, et al. Genipin suppresses subconjunctival fibroblast migration, proliferation and myofibroblast differentiation. Ophthalmic Res 2006;38:355-360 (Pubitemid 44704502)